INTRODUCTION
============

Acute subdural hematoma (ASDH) generally considered a condition that should be managed surgically, but in some cases may be treated conservatively[@b1-jkns-60-6-723]. Minimally symptomatic ASDH patients do not always require early surgical evacuation[@b3-jkns-60-6-723]. In minimal ASDH patients, initial treatment is typically determined according to surgical guidelines and the surgeon's experience[@b2-jkns-60-6-723]. With advances of radiological diagnostic tools, the number of patients with minimal subdural hematoma (SDH) who are treated conservatively is increasing. However, some ASDH patients managed with conservative treatment require surgical intervention later[@b28-jkns-60-6-723]. Hemorrhage resulting from injury of the bridging veins is liquefied with micro-bleeding and progresses to symptomatic chronic subdural hematoma (CSDH) as expanding[@b8-jkns-60-6-723]. Patients with progression to CSDH require surgical decompression such as craniotomy and Burr hole trephination with or without irrigation and drainage[@b8-jkns-60-6-723]. Therefore, it is important to know the conditions when the SDH progresses and who will require surgical intervention. The purpose of this study was to identify predictable risk factors that are associated with ASDH patients who are initially managed conservatively undergoing delayed surgical intervention.

MATERIALS AND METHODS
=====================

We retrospectively collected data from 842 patients diagnosed with SDH who were treated at the neurosurgery department of our tertiary medical center between January 2007 and December 2015. Two hundred fifty-seven patients underwent emergency craniectomy and hematoma evacuation. Cases of minimal falx or subtentorial hemorrhage (n=280), which commonly does not require surgery, were not included. Patients younger than 15 years old (n=37) or who received surgical intervention within 7 days after diagnosis (n=47) were excluded. Sixty-three patients who died or refused treatment were also excluded ([Fig. 1](#f1-jkns-60-6-723){ref-type="fig"}).

Finally, 158 patients were enrolled in the study. All patients were admitted to the neurosurgical department and initially treated conservatively. Anti-epileptic drugs were administered to all patients, and osmotic diuretics were given when needed. Anti-platelet agents and anticoagulation agents were halted at the time of diagnosis. If patents demonstrated coagulopathy on initial laboratory findings, such as low platelet count or prolonged international normalized ratio (INR), the issue was corrected with platelet and fresh frozen plasma transfusion or IV administration of vitamin K.

Patients' medical histories were retrospectively collected by chart review. Past medical comorbidities, medication, and trauma histories were reviewed. Radiological and laboratory studies were performed at the time of diagnosis, and follow-up brain computed tomography (CT) scanning was performed routinely within the first 8 hours and every 1 week unless neurological deterioration was observed.

Radiological findings were obtained by chart review. All films were interpreted by a radiologist when the patient was admitted and confirmed by neurosurgeons. On the initial brain CT scan, intracranial injuries accompanying SDH, such as intraparenchymal hemorrhage or subarachnoid hemorrhage, were evaluated, and maximal hematoma thickness and midline shifting were measured.

Surgery was performed when follow-up brain CT scan revealed hematoma progression or a mass effect appeared such as headache aggravation or development of a neurological deficit. All such patients underwent Burr hole trephination and drainage with or without irrigation under general or local anesthesia.

Chi-square and Fisher's exact test were utilized to analyze categorical data, and numerical variables were compared with Student's t-test. Statistical differences were considered significant for *p* values less than 0.05. Finally, to adjust for relationships among various factors, multivariate logistic regression was used to identify independent risk factors.

RESULTS
=======

The 158 patients enrolled in this study were all initially treated conservatively. They were divided into two groups according to follow-up treatment: the conservative treatment group (n=130) and surgical treatment group (n=28). Patient characteristics are listed in [Tables 1](#t1-jkns-60-6-723){ref-type="table"} and [2](#t2-jkns-60-6-723){ref-type="table"}. All patients presented minor symptoms, such as headache, dizziness, nausea, or vomiting. No definite neurologic deficit was observed. Patients' mean age was 62.93 years; 112 patients (70.9%) were male, 46 (29.1%) were female. Twenty-eight patients (17.7%) demonstrated progression of SDH on follow-up brain CT and underwent surgical intervention. The mean interval between initial diagnosis to operation was 13.9 days.

Patients in the surgical group were older than those in the conservative group (mean age 69.00 vs. 61.62 years, *p*=0.024). However, there was no significant difference in sex distribution, with 89 males and 41 females in the conservative group and 23 males and 5 females in the surgical group (*p*=0.229).

In total, 69 patients had hypertension: 53 in the conservative group and 16 in the surgical group, with no significant difference between groups (*p*=0.113). Rates of diabetes mellitus (DM) and cardiac disease history did not differ between the groups (*p*=0.966 and *p*=0.506), while history of cerebral infarction significantly more in surgical group (*p*=0.026). Medication rates did not differ between the two groups. Eighteen patients in the conservative group and 5 in surgical group were taking anti-platelet agents. Two patients were on anti-coagulant agents, one in each group.

The initial brain CT scans of patients in surgical group showed greater in maximal thickness (11.54 vs. 5.78 mm, *p*\<0.001) and more midline shifting to the opposite hemisphere compared to the conservative group (3.32 vs. 1.08 mm, *p*=0.001).

On initial brain CT scan, 45 patients had subarachnoid hemorrhage, and 26 patients had intraparenchymal hemorrhage. The conservative group included a significantly higher proportion of patients with subarachnoid hemorrhage (42 vs. 3, *p*=0.022), but no difference was seen in intraparenchymal hemorrhage (22 vs. 4, *p*=1).

Among the initial laboratory findings, prothrombin time (INR) and platelet count did not differ between the two groups (*p*=0.522 and *p*=0.279). However, initial hemoglobin was negatively correlated with surgical intervention (12.25 vs. 13.53, *p*=0.001). Leukocyte count was also higher in the surgical group than in the conservative group (89.0 vs. 58.6, *p*=0.005). By contrast, initial glucose was lower in the surgical group (134.6 vs. 157.3, *p*=0.005).

To correct for confounding factors, we performed a multivariate logistic regression analysis including possible risk factors with *p* values less than 0.01 on univariate analysis. Multivariate logistic regression analysis identified initial SDH thickness (odds ratio \[OR\]=1.279, 95% confidence interval \[CI\] 1.075--1.521; *p*=0.006) and leukocyte count (OR=1.142, 95% CI 1.024--1.272; *p*=0.017; [Table 3](#t3-jkns-60-6-723){ref-type="table"}) as independent risk factors for delayed surgical intervention. Additionally, initial hemoglobin was confirmed as an independent negative predictor of hematoma progression (OR=0.673, 95% CI 0.467--0.970; *p*=0.034). Age (*p*=0.692), history of cerebral infarction (*p*=0.993), midline shifting (*p*=0.191), accompanying SAH (*p*=0.747), and glucose level (*p*=0.254) were not significantly associated with surgical intervention.

DISCUSSION
==========

A few previous reports have investigated the risk factors of delayed surgical intervention in initially conservatively treated traumatic ASDH patients ([Table 4](#t4-jkns-60-6-723){ref-type="table"}). According to previous studies, 12.6% of ASDH patients developed CSDH that required delayed surgical intervention. In this study, 28 patients (17.7%) showed progression of SDH and required surgical decompression. They presented aggravation of headache, dysarthria, gait disturbance, or subjective motor weakness. These patients underwent Burr hole trephination and drainage under general or local anesthesia an average of 13.9 days after admission, and none showed neurological deterioration after surgery.

Older patients with minimal ASDH in elderly were more likely to undergo delayed surgery than younger patients. Physiology factors in the brain, such as low elasticity, vulnerable bridging veins, and atrophy, makes older people more susceptible to head injury[@b12-jkns-60-6-723],[@b15-jkns-60-6-723]. In the present study, mean age was significantly higher in the surgical group than the conservative group (69.00 vs. 61.62 years) in univariate analysis (*p*=0.024) but not multivariate analysis. These findings suggest that aging is not an independent factor, but may be related to other co-morbidities or physiological factors[@b2-jkns-60-6-723],[@b5-jkns-60-6-723],[@b6-jkns-60-6-723],[@b12-jkns-60-6-723].

Previous studies have reported conflicting results regarding whether hypertension influences the risk of delayed surgery. In the present study, hypertension demonstrated no significant correlation with delayed surgical intervention. These findings may suggest that hypertension is not an independent risk factor for SDH progression. But some previous studies showed the relationship between hypertension and delayed surgery, future research should focus on risk factors influenced by hypertension[@b7-jkns-60-6-723],[@b10-jkns-60-6-723]. Previous studies have also reported conflicting results on the association between DM and SDH progression[@b7-jkns-60-6-723],[@b9-jkns-60-6-723]--[@b11-jkns-60-6-723]. Han et al.[@b7-jkns-60-6-723] suggested that DM vasculopathy may play a role in re-bleeding in SDH, while DM was found not to be a risk factor for the progression of ASDH to CSDH. In DM patients, it has been proposed that higher blood osmotic pressure induces hyperviscosity and increases platelet aggregation, thus potentially decreasing re-bleeding in SDH patients[@b25-jkns-60-6-723],[@b29-jkns-60-6-723].

We expected that history of cardiovascular or cerebrovascular disease and usage of anti-coagulant or anti-platelet agents would influence delayed surgery. However, only history of cerebrovascular disease significantly differed between the two groups. Cerebral infarction leads to a reduction in brain parenchyma volume, creating a larger subdural space. Consequently, patients are at greater risk of SDH progression[@b19-jkns-60-6-723]. Use of anti-platelet agents was shown to increase the risk of morbidity and mortality in ASDH patients[@b21-jkns-60-6-723]. Among the previous studies on SDH progression, Kim et al.[@b9-jkns-60-6-723], Lee et al.[@b11-jkns-60-6-723], and Bajsarowicz et al.[@b1-jkns-60-6-723] reported that use of anti-platelet agents does not influence delayed surgery. By contrast, Laviv and Rappaport[@b10-jkns-60-6-723] and Tseng et al.[@b26-jkns-60-6-723] reported that use of anti-platelet agents increases the risk of delayed surgery. Consistent with the former group, in the present study, use of anti-platelet agents did not increase the risk of delayed surgical intervention. Use of anti-platelet agents increases the risk of re-bleeding, is associated with liquefaction of SDH, and facilitates early redistribution of hematoma. Han et al.[@b7-jkns-60-6-723] suggested that anti-platelet agents affect hematoma liquidity, allowing the hematoma to be more easily washed out by cerebrospinal fluid flow[@b18-jkns-60-6-723],[@b27-jkns-60-6-723]. Cessation and correction of coagulation abnormality could play a role in reducing the risk of delayed surgery. Additionally, it is possible that patients on anti-platelet agents might have had a much thicker SDH requiring emergency surgical decompression or refused intensive treatment, leading them to be excluded from this study.

We found that greater SDH thickness and midline shifting were associated with delayed surgical intervention, and SDH thickness was an independent risk factor for SDH progression. Midline shifting is influenced by SDH thickness, and smaller initial SDH thickness could be considered to reflect greater stability. A thicker hematoma can stress the bridging veins more severely and make them vulnerable to tearing[@b13-jkns-60-6-723], resulting in hematoma expansion. Through a combination of persistent inflammatory reaction, neoangiogenesis, collection of subdural fluid, and repeated coagulation and fibrinolysis, it the hematoma develops a neomembrane[@b17-jkns-60-6-723],[@b23-jkns-60-6-723],[@b24-jkns-60-6-723]. Consequently, initially large SDH require more time to be washed out and have a greater risk of transforming to chronic SDH.

We analyzed the accompanying intracranial injuries on all patients' initial brain CT scan. Focal intraparenchymal hemorrhage was not associated with delayed surgery. However, concomitant subarachnoid hemorrhage was more frequently seen in the conservative group. Combined subarachnoid hemorrhage could make the parenchymal swelling. Brain swelling after head injury compresses the hematoma, leading to redistribution[@b6-jkns-60-6-723]. It is possible that an edematous cerebral condition might reduce the free subdural space between the skull and parenchyma, preventing the progression of SDH[@b14-jkns-60-6-723].

In addition, we collected initial laboratory findings for all patients. Among the initial complete blood cell count, hemoglobin demonstrated an independent negative correlation with delayed surgery, and leukocytes demonstrated an independent positive correlation with surgery. Low hemoglobin count could be considered to reflect the aging process, but also indicates low viscosity of the blood. Viscosity has an important role in coagulation pathways. Low hemoglobin indicates low viscosity of the blood, and these patients have tendency for micro-bleeds and progression to CSDH[@b20-jkns-60-6-723]. CSDH is also a consequence of inflammatory reactions in hematoma[@b23-jkns-60-6-723],[@b24-jkns-60-6-723]. Previous reports suggested that eosinophil granulation is associated with SDH membrane formation[@b16-jkns-60-6-723],[@b22-jkns-60-6-723],[@b30-jkns-60-6-723]. Another previous study indicated that the inflammatory reaction is the key role in progression of the CSDH. Leukocytes, eosinophils, macrophages and inflammatory cytokines were elevated and play the important role of progression. At this point of view, an elevated leukocyte count could be interpreted as a marker of inflammatory processes. Pro- and anti-inflammatory cytokines encourage the neoangiogenesis[@b4-jkns-60-6-723]. So patients with a high leukocyte count, more easily form a hematoma neomembrane. Moreover, leukocytes, especially neutrophils, are thought to mediate the exacerbation of secondary brain injury in intracerebral hemorrhage by releasing additional pro-inflammatory proteases that affect blood-brain barrier permeability[@b31-jkns-60-6-723],[@b32-jkns-60-6-723]. Therefore, relieving the inflammatory condition might reduce the risk of delayed surgery and secondary brain injury[@b4-jkns-60-6-723], and further studies should focus on the association of CSDH progression and inflammatory markers including not only leukocyte count but also specific cell types (eosinophils, neutrophils, and basophils) and other markers such as erythrocyte sedimentation rate and C-reactive protein.

Initial low glucose was also a risk factor for surgical intervention, which could be considered from the same point of view as hemoglobin. High glucose indicates high viscosity of the blood, which could facilitate hemostasis. This phenomenon could in turn prevent additional bleeding and halt the SDH expansion.

CONCLUSION
==========

In this study, 17.7% of initially conservatively treated ASDH patients developed CSDH and required delayed surgical intervention. Greater initial hematoma thickness, low hemoglobin, and high leukocyte count were identified as independent risk factors of hematoma progression. Therefore, patients with thicker hematomas on initial brain CT and low hemoglobin or high leukocyte count require more careful observation to prevent delayed surgical intervention.
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###### 

Characteristics, past medical and medication histories of conservative group and surgical group

  Variable            Conservative (n=130)   Surgery (n=28)   *p*-value
  ------------------- ---------------------- ---------------- -----------
  Age                 61.62±15.65            69.00±15.01      0.024
                                                              
  Sex (male)          89: 41 (68.5)          23: 5 (82.1)     0.148
                                                              
  Comorbidity                                                 
   HTN                53 (40.8)              16 (57.1)        0.113
   DM                 33 (25.4)              7 (25.0)         0.966
   Heart disease      13 (10.0)              4 (14.3)         0.506
   Prev. infarction   6 (4.6)                5 (17.9)         0.026
                                                              
  Anti-PLT            18 (13.8)              5 (17.9)         0.563
                                                              
  Anticoagulant       1 (0.8)                1 (3.6)          0.324

Values are presented as mean±standard deviation or number (%) unless otherwise indicated. HTN: hypertension, DM: diabetes mellitus, PLT: platelet

###### 

Radiologic and laboratory findings of conservative group and surgical group

  Variable         Conservative (n=130)   Surgery (n=28)   *p*-value
  ---------------- ---------------------- ---------------- -----------
  Radiology                                                
   Thickness       5.78±3.27              11.54±5.16       \<0.001
   Midline shift   1.08±2.36              3.32±3.13        0.001
   Bilaterality    23 (17.7)              6 (21.4)         0.643
   SAH             42 (32.3)              3 (10.7)         0.022
   ICH             22 (16.9)              4 (14.3)         1
                                                           
  Laboratory                                               
   Leukocyte       5.82±5.63              9.00±4.83        0.004
   Hemoglobin      13.56±1.78             12.18±2.07       \<0.001
   Platelet        216.87±186.78          175.00±63.91     0.244
   Glucose         157.65±59.36           132.64±27.51     0.002
   INR             1.14±1.08              1.00±0.01        0.52

Values are presented as mean±standard deviation or number (%). SAH: subarachnoid hemorrhage, ICH: intracerebral hemorrhage, INR: international normalized ratio

###### 

Result of multivariate analysis

  Variable     *p*-value   Odds ratio   95% confidence interval
  ------------ ----------- ------------ -------------------------
  Thickness    0.006       1.279        1.075--1.521
  Leukocyte    0.017       1.142        1.024--1.272
  Hemoglobin   0.034       0.673        0.467--0.970

###### 

Previous reports on progression of hematoma in initially conservatively treated ASDH patients

  --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                            Country      Study population   Surgical group   Country      Risk factors            Not risk factor
  ------------------------------------------------ ------------ ------------------ ---------------- ------------ ----------------------- -----------------------
  Laviv and Rappaport (2014)[@b10-jkns-60-6-723]   Istrael      95                 43 (45.2)        Israel       IHD\                    DM\
                                                                                                                 HTN\                    Bilaterality
                                                                                                                 ACE-inhibitor\          
                                                                                                                 Anticoagulant\          
                                                                                                                 Clopidogrel\            
                                                                                                                 Size of SDH             

  Lee et al. (2015)[@b11-jkns-60-6-723]            Korea        117                16 (13.7)        Korea        Age\                    HTN\
                                                                                                                 Midline shifting\       DM\
                                                                                                                 Hematoma depth\         SAH\
                                                                                                                 Hounsfield Unit         H. contusion\
                                                                                                                                         Bilaterality\
                                                                                                                                         Midline shifting\
                                                                                                                                         Aspirin, clopidogrel\
                                                                                                                                         Warfarin

  Kim et al. (2014)[@b9-jkns-60-6-723]             Korea        98                 34 (34.7)        Korea        Thickness\              Sex\
                                                                                                                 Hematoma volume\        Combined hemorrhage\
                                                                                                                 Midline shifting\       Warfarin
                                                                                                                 H. contusion\           
                                                                                                                 SAH                     

  Han et al. (2014)[@b7-jkns-60-6-723]             Korea        277                20 (7.2)         Korea        HTN\                    Age\
                                                                                                                 DM\                     Sex\
                                                                                                                 Cb. Infarction\         Gcs\
                                                                                                                 Anti-PLT\               Anticoagulant\
                                                                                                                 Location (convexity)\   Anti-PLT
                                                                                                                 Encephalomalacia        

  Bajsarowicz et al. (2015)[@b1-jkns-60-6-723]     Canada USA   647                42 (6.5)         Canada USA   Prev. fall\             Age\
                                                                                                                 Alcohol\                Sex\
                                                                                                                 Location (convexity)\   INR\
                                                                                                                 Thickness\              Thickness\
                                                                                                                 Midline shifting        Midline shifting
  --------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are presented as number (%). ASDH: acute subdural hematoma, IHD: ischemic heart disease, HTN: hypertension, ACE: angiotensin-converting-enzyme, DM: diabetes mellitus, H.: hemorrhagic, Cb.: cerebral, PLT: platelet, GCS: Glasgow coma scale, Prev.: previous
